Cytomegalovirus retinitis following dexamethasone intravitreal implant

Sarah G. Chaudhry, Adrian T. Fung*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
68 Downloads (Pure)

Abstract

Purpose: To describe a case of Cytomegalovirus (CMV) Retinitis in an immunocompetent patient following Dexamethasone Intravitreal Implant (DII). Observations: Retrospective chart review of a single patient. An 80-year-old immunocompetent male presented with floaters in his left eye 10 weeks after his DII. He was noted to have a visual acuity of 20/1200 in his left eye and a panuveitis with CMV retinitis. The patient underwent a vitreous biopsy and given immediate intravitreal foscarnet and an ongoing management regimen of oral valganciclovir for two months. His vision improved to 20/200 and his CMV retinitis resolved. Conclusion and Importance: DII can trigger CMV retinitis in immunocompetent patients.

Original languageEnglish
Article number101055
Pages (from-to)1-3
Number of pages3
JournalAmerican Journal of Ophthalmology Case Reports
Volume22
DOIs
Publication statusPublished - Jun 2021

Bibliographical note

Copyright the Author(s) 2021. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Cytomegalovirus (CMV)
  • Dexamethasone intravitreal implant (DII)
  • Immunocompetent
  • Retinitis

Fingerprint

Dive into the research topics of 'Cytomegalovirus retinitis following dexamethasone intravitreal implant'. Together they form a unique fingerprint.

Cite this